1 / 25

Promoting Diversity and Science for Health Equity -- Introduction of NIDA

Promoting Diversity and Science for Health Equity -- Introduction of NIDA Minority Diversity Programs Yu (Woody) Lin, M.D., Ph.D Program Director Division of Clinical Neuroscience and Behavior Research National Institute on Drug Abuse/NIH. NIH Mission.

minnie
Download Presentation

Promoting Diversity and Science for Health Equity -- Introduction of NIDA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Promoting Diversity and Science for Health Equity -- Introduction of NIDA Minority Diversity Programs Yu (Woody) Lin, M.D., Ph.D Program Director Division of Clinical Neuroscience and Behavior Research National Institute on Drug Abuse/NIH

  2. NIH Mission NIH is the steward of medical and behavioral research for the Nation Our mission: to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability … • Support research by non-Federal scientists across U.S. and abroad • Help train research investigators • Foster communication of medical and health sciences information

  3. Total NIH Budget Authority – FY 2011$32.23 Billion Research Project Grants 53% $16.42 Billion Training 2% $722 Million

  4. NIDA’s Mission Bring the power of science to bear research on drug abuse and addiction • Support and conduct cross-disciplinary • research to better understand, treat • and prevent drug abuse and addiction • Disseminate research results to improve • prevention, treatment, and policy

  5. From Molecules… …To Genetics …Drug Courts …Health Services Research NIDA Research … Behavioral Treatment

  6. NIDA BUDGET (Thousands) 2013PB 2011 2012 NonAIDS $731,428 $317,348 $1,048,776 -1.0% $732,838 $321,163 $1,054,001 0.2% $732,822 $319,292 $1,052,114 0.3% AIDS TOTAL Increase Over Prior Year

  7. National Institute on Drug Abuse Portfolio FY 2010 Actual Basic & Clinical Neuroscience & Behavioral Research -- 46% Epidemiology, Services & Prevention Research -- 23% Pharmacotherapies & Medical Consequences -- 12% Clinical Trials Network -- 4% Intramural Research -- 8% RM&S -- 6%

  8. NIDA National Institute on Drug Abuse Office of the Director Nora D. Volkow, MD Director David Shurtleff, PhD Acting Deputy Director Glenda Conroy Executive Officer Special Populations Office David Shurtleff, PhD HIV/AIDS Research Jacques Normand, PhD Gender Research Cora Lee Wetherington, PhD International Program Steve Gust, PhD Office of Planning & Resource Management Helio Chaves Center for the Clinical Trials Network Betty Tai, PhD Office of Science Policy & Communications Susan Weiss, PhD • Office of Extramural Affairs • Teresa Levitin, PhD Division of Clinical Neuroscience & Behavioral Research Joseph Frascella, PhD Division of Pharmacotherapies & Medical Consequences of Drug Abuse David McCann, PhD Division of Epidemiology, Services & Prevention Research Wilson Compton, MD, MPE Division of Basic Neuroscience & Behavioral Research Joni Rutter, PhD Intramural Research Program Anto Bonci, MD

  9. Special Populations Office (SPO) • Increase diverse workforce & activity • Promote science for health equity

  10. Special Populations Office (SPO) The NIDA SPO coordinates the Institute’s diversity-directed research, concentrating on areas where there are significant gaps in knowledge and/or clear Disparities in prevention and treatment. SPO DIRECTOR SPO STAFF NA/AN RS Workgroup AAPI RS Workgroup AA RS Workgroup NHSN Workgroup NIDA Diversity Research Program

  11. Researchers & Scholars Workgroups • Each Work Group is currently comprised of established researchers and scholars with expertise in drug abuse and addiction research and health concerns of the particular population it represents. • Provide guidance and recommendations to NIDA: • Drug abuse and addiction research development • Training needs within 4 major diverse populations • Identify concerns, and stimulate research on drug abuse/addiction associated with particular population it represents. American Indian/ Alaska Native Work Group African American Work Group

  12. SPO Research & Training Programs Promoting Diversity and Science for Health Equity • Diversity -promoting Institutions Drug Abuse Research Program (DIDARP) • Diversity Supplements • Research Development Seminar Series • Summer Research with NIDA

  13. NIDA Diversity-Promoting Institutions Drug Abuse Research Program (DIDARP) The overall goal of the DIDARP is the capacity development of the applicant institution to support drug abuse research through the following objectives: (1) Provide faculty with drug abuse research knowledge and skill development through the conduct of research projects and other professional development activities; Encourage students from disadvantaged backgrounds to pursue drug abuse research careers by providing them with educational enrichment and research experiences; (3) Strengthen the underlying institutional infrastructure needed to support drug abuse research.  (4) Budgets up to $350,000 (direct costs/year (5 years); NIDA review, division fund http://grants.nih.gov/grants/guide/pa-files/PAR-11-060.html

  14. NIDA Diversity-Promoting Institutions Drug Abuse Research Program (DIDARP) Since 2005, NIDA has supported 15 DIDARPs. There are 11 active DIDARP projects; including these 7 institutions that have not been previously supported: • University of Houston • Howard University • Meharry Medical College • Morehouse School of Medicine • University of Puerto Rico School of Public Health • California State University – San Bernandino • University of Hawaii • NIDA Program Contact: Pamela Goodlow

  15. Diversity Supplements Program • Supplements certain active (> 1 year) research grants • Provides mentoring/training for an identified individual from an underrepresented or disadvantaged population: • * Racial/Ethnic Minority * Investigator who becomes disabled* Individual with disability * Disadvantaged Background • Supports persons at five levels: • * High school * Undergraduates* Graduate students * Post doctoral* Investigators • NIDA internal review; a NIH-wide program • Type/Amount of support varies with levelsNIDA Program Contact: Pamela Goodlow

  16. NIDA Diversity Supplement Awards

  17. Research Development Seminar Series • For scholars from diverse populations who are trained & dedicated for independent research on drug abuse yet need technical assistance on grant application process • Provides science and proposal development lectures in 2 training sessions about 6 months apart: • First focuses on research design, methods, scientific writing, the peer review process and grant application preparation • Second centers on mock review led by NIDA SRA • Small group discussion, and one-on-one mentoring provided by NIDA staff and extramural experts in the field of drug abuse and addiction research • NIDA Program Contact: Flair Lindsey

  18. Research Development Seminar Series • Must prepare a 1-page concept paper • Actively participate in proposal developmentactivities • Expectation is that your application will be submitted within 6 – 12 months after your last session • Program established in 1986. From 2009 – 2011 NIDA supported 57 early career researchers to attend the Seminar Series

  19. Examples of NIDA-Supported Research In Diverse Communities • Patterns of Substance Abuse • Biological & Behavioral Risk & Protective Factors • Relationship of Stress to Drug Use & Other Disorders • Culturally Appropriate Prevention Interventions • Preventive Interventions with Urban Youth • Culturally Appropriate Substance Abuse • Treatment Strategies • Tobacco Cessation • Treatment Services Research

  20. NIDA Summer Research Internship Program • Supports under-represented high school and undergraduate students in the social sciences and life sciences • 8-10 week research placement with NIDA grantees

  21. Summer Research with NIDA Program Participation - All Years

  22. NIDA Minority Diversity Programs • Preparing researchers to better address minority health disparities • Stimulating/Encouraging research that will lead to more effective drug abuse and drug abuse related prevention and treatment approaches for racial/ethnic minority populations • Increasing the number of racial/ethnic minority researchers engaged in drug abuse and related research

  23. National Institute on Drug Abuse • NIDA Has Made a Commitment in You • Believe in your research skills and abilities • Your research has the potential to make an impact in the substance abuse and health disparities field

  24. Questions?

  25. National Institute on Minority Health and Health Disparities In 2010, NIH announced the transition of the National Center on Minority Health and Health Disparities (NCMHD) into the National Institute on Minority Health and Health Disparities (NIMHD). This transition gives the institute a more defined role in the NIH's research agenda against health disparities, which it defines as differences in the incidence, prevalence, mortality, and burden of diseases and other adverse health conditions that exist among specific population groups. Funding Opportunity Announcements: NIMHD Basic and Applied Biomedical Research on Minority Health and Health Disparities (R01) RFA-MD-12-004 NIMHD Social, Behavioral, Health Services, and Policy Research on Minority Health and Health Disparities (R01)RFA-MD-12-003 Conferences and Scientific Meetings PA-10-071

More Related